Overview Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides Status: Completed Trial end date: 2001-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the effect of gemcabene on HDL-C, LDL-C, TG, and other lipid levels in patients with low HDL-C Phase: Phase 2 Details Lead Sponsor: Gemphire Therapeutics, Inc.NeuroBo Pharmaceuticals Inc.